Patents by Inventor Peggy Wentworth

Peggy Wentworth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING AND AMELIORATING CANCER
    Publication number: 20240148688
    Abstract: In alternative embodiments, provided are methods for treating and ameliorating a cancer, or recurrence of a cancer such as acute myeloid leukemia (AML) comprising administration to an individual in need thereof a pharmaceutical composition comprising 17S-FD-895 (or rebecsinib) and second drug such as an ATP-competitive protein tyrosine kinase inhibitor such as dasatinib. In alternative embodiments, provided are methods for the in vivo inhibition of myeloproliferative neoplasm (MPN) or AML stem cell propagation comprising administration to an individual in need thereof a pharmaceutical composition comprising 17S-FD-895 and second drug. In alternative embodiments, provided are methods for the in vivo inhibition pre-leukemia stem cell (pre-LSC) transformation into leukemia stem cells (LSCs) comprising administration to an individual in need thereof a pharmaceutical composition comprising 17S-FD-895 and second drug.
    Type: Application
    Filed: February 1, 2022
    Publication date: May 9, 2024
    Inventors: Catriona JAMIESON, Leslie CREWS ROBERTSON, Michael BURKART, Larisa BALAIAN, Phoebe MONDALA, Cayla MASON, Raymond H. DIEP, James LACLAIR, Thomas WHISENANT, Warren C. CHAN, Inge VAN DER WERF, Peggy WENTWORTH, Wenxue MA
  • Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of CTL
    Patent number: 5846827
    Abstract: Methods for activating cytotoxic T lymphocytes (CTL) in vitro are presented in conjunction with methods for using the activated CTL for therapy in vivo. Additionally, a method for killing specific CTL in vivo is presented using antigen presenting cells which were modified in vitro.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 8, 1998
    Assignee: Cytel Corporation
    Inventors: Esteban Celis, Ralph Kubo, Horacio Serra, Van Tsai, Peggy Wentworth